Curcumin modulation of atherosclerosis and hepatosteatosis in LDLr-/- mice

被引：0
|
作者：
Hasan, Syeda Tahira [1 ]
Zingg, Jean-Marc [1 ]
Noble, Timothy [1 ]
Kwan, Paul [3 ]
Smith, Donald [2 ]
Meydani, Mohsen [1 ]
机构：
[1] Tufts Univ, HNRCA, Vasc Biol Lab, Boston, MA 02111 USA
[2] Tufts Univ, HNRCA, Comparat Biol Unit, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
359.1
引用
收藏
页数：1
相关论文
共 50 条
  • [11] MHCII-Deficiency attenuates the development of atherosclerosis in LDLR-/- Mice
    Smock, Marjan L.
    Heeringa, Peter
    van de Gaar, Jose
    Daemen, Mat J.
    Willem, Jan
    Tervaert, Cohen
    Lingens, Esther
    CIRCULATION, 2006, 114 (18) : 287 - 287
  • [12] Antibodies against electronegative LDL inhibit atherosclerosis in LDLR-/- mice
    Grosso, DM
    Santos, L
    Bonito, A
    Krieger, MH
    Abdalla, DSP
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 40 - 40
  • [13] Antibodies against electronegative ldl inhibit atherosclerosis in ldlr-/- mice
    Grosso, DM
    Santos, L
    Bonito, A
    Krieger, MH
    Abdalla, DSP
    JOURNAL OF BIOTECHNOLOGY, 2005, 118 : S69 - S69
  • [14] The immunosuppresant everolimus significantly prevents atherosclerosis in hypercholesterolemic LDLR-/- mice
    Mueller, M. A.
    Beutner, F.
    Teupser, D.
    Ceglarek, U.
    Jeromin, F.
    Weise, C.
    Thiery, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 464 - 464
  • [15] Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr-/- Mice
    Peng, Xueying
    Lian, Zeqin
    Perrard, Xiao-Yuan Dai
    Xiao, Yunjie
    Ni, Jing
    O'Brien, Veronica
    Dong, Henry
    Pownall, Henry J.
    Ballantyne, Christie M.
    Wu, Huaizhu
    CELLS, 2022, 11 (11)
  • [16] EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR-/- MICE
    Brendel, D.
    Beutner, F.
    Teupser, D.
    Mueller, M.
    Baber, R.
    Jeromin, F.
    Wilfert, W.
    Ceglarek, U.
    Thiery, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 178 - 179
  • [17] Adipsin deficiency does not impact atherosclerosis development in Ldlr-/- mice
    Liu, Longhua
    Chan, Michelle
    Yu, Lexiang
    Wang, Weidong
    Qiang, Li
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (01): : 87 - 92
  • [18] Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice
    Grosso, D. M.
    Ferderbar, S.
    Wanschel, A. C. B. A.
    Krieger, M. H.
    Higushi, M. L.
    Abdalla, D. S. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2008, 41 (12) : 1086 - 1092
  • [19] Interleukin-27 Receptor Limits Atherosclerosis in Ldlr-/- Mice
    Koltsova, Ekaterina K.
    Kim, Gisen
    Lloyd, Kathleen M.
    Saris, Christiaan J. M.
    von Vietinghoff, Sibylle
    Kronenberg, Mitchell
    Ley, Klaus
    CIRCULATION RESEARCH, 2012, 111 (10) : 1274 - U118
  • [20] EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR-/- MICE
    Brendel, D.
    Beutner, F.
    Mueller, M.
    Teupser, D.
    Baber, R.
    Ceglarek, U.
    Thiery, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345